Evidence map›Paper›PMID 37772937›Full record

ArticleNeuro-oncology2024

Integrating single-cell and spatial transcriptomics reveals endoplasmic reticulum stress-related CAF subpopulations associated with chordoma progression.

Tao-Lan Zhang, Chao Xia, Bo-Wen Zheng, Hai-Hong Hu, Ling-Xiang Jiang, David Escobar, Bo-Yv Zheng, Tian-Dong Chen, Jing Li, Guo-Hua Lv and 3 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Neuro-oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Advances in Spatial Transcriptomics in Bone.Current osteoporosis reports · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Tao-Lan ZhangInstitute of Clinical Medicine, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Chao XiaDepartment of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Bo-Wen ZhengInstitute of Clinical Medicine, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Hai-Hong HuInstitute of Clinical Medicine, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Ling-Xiang JiangDepartment of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
David EscobarDepartment of Cancer Biology, University of Toledo, College of Medicine & Life Sciences, Toledo, Ohio, USA.
Bo-Yv ZhengDepartment of Orthopedics Surgery, General Hospital of the Central Theater Command, Wuhan, China.
Tian-Dong ChenDepartment of Pathology, The Affiliated Henan Provincial Cancer Hospital, Zhengzhou University, Zhengzhou, China.
Jing LiDepartment of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Guo-Hua LvDepartment of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Wei HuangThe First Affiliated Hospital, Health Management Center, Hengyang Medical School, University of South China, Hengyang, China.
Yi-Guo YanDepartment of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Ming-Xiang ZouDepartment of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.ORCID 0000-0002-4516-3917
University of South China · CNCentral South University · CNPeking University · CNIndiana University Health · USUniversity of Toledo · USZhengzhou University · CN

Funding

China Scholarship Council 202106370071National Natural Science Foundation of China 82003802Natural Science Foundation of Hunan Province 2019JJ50542
6 · The paper itself

Abstract

backgroundWith cancer-associated fibroblasts (CAFs) as the main cell type, the rich myxoid stromal components in chordoma tissues may likely contribute to its development and progression.

methodsSingle-cell RNA sequencing (scRNA-seq), spatial transcriptomics, bulk RNA-seq, and multiplexed quantitative immunofluorescence (QIF) were used to dissect the heterogeneity, spatial distribution, and clinical implication of CAFs in chordoma.

resultsWe sequenced here 72 097 single cells from 3 primary and 3 recurrent tumor samples, as well as 3 nucleus pulposus samples as controls using scRNA-seq. We identified a unique cluster of CAF in recurrent tumors that highly expressed hypoxic genes and was functionally enriched in endoplasmic reticulum stress (ERS). Pseudotime trajectory and cell communication analyses showed that this ERS-CAF subpopulation originated from normal fibroblasts and widely interacted with tumoral and immune cells. Analyzing the bulk RNA-seq data from 126 patients, we found that the ERS-CAF signature score was associated with the invasion and poor prognosis of chordoma. By integrating the results of scRNA-seq with spatial transcriptomics, we demonstrated the existence of ERS-CAF in chordoma tissues and revealed that this CAF subtype displayed the most proximity to its surrounding tumor cells. In subsequent QIF validation involving 105 additional patients, we confirmed that ERS-CAF was abundant in the chordoma microenvironment and located close to tumor cells. Furthermore, both ERS-CAF density and its distance to tumor cells were correlated with tumor malignant phenotype and adverse patient outcomes.

conclusionsThese findings depict the CAF landscape for chordoma and may provide insights into the development of novel treatment approaches.

Indexed as

Cancer-Associated FibroblastsChordomaEndoplasmic Reticulum StressGene Expression ProfilingHumansRNA-SeqTumor Microenvironmentcancer-associated fibroblastschordoma progressionendoplasmic reticulum stressscRNA-seqspatial transcriptomics

Identifiers

PMID37772937
PMCPMC10836767
OpenAlexW4387151869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.